Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04243538 · ClinicalTrials.gov registry record · NA

Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice

A NA study of Hospice, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04243538 is a NA study of Hospice that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 80 participants, above the 52-participant average among 3 other Hospice trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04243538, a NA study of Hospice, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it has shown promise to improve care in other settings. Therefore, this study aims to develop and evaluate a multi-component technology-based care intervention, i.e., Improving Home hospice Management of End of life issues through technology (I-HoME).

Conditions Studied

Interventions

  • BEHAVIORAL I-HoME

Study Locations (1)

New York

  • The Visiting Nurse Service of New York - New York

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-02-14
Est. Completion 2024-10-10
Phase NA

What the Registry Record Tells You About NCT04243538

The ClinicalTrials.gov registry entry for NCT04243538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 3 other Hospice trials with a reported enrollment target (54% higher). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hospice appearing as the primary indexed condition, and to 1 intervention - of which I-HoME is the first listed.

NCT04243538 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04243538 about?

NCT04243538 is a clinical study titled "Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice". With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it ha...

What is the current status of trial NCT04243538?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-02-14. Estimated completion is 2024-10-10.

What conditions does trial NCT04243538 study?

This clinical trial studies the following conditions: Hospice.

What interventions are being tested in trial NCT04243538?

The interventions under investigation include: I-HoME (BEHAVIORAL).

Who is sponsoring clinical trial NCT04243538?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04243538 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hospice

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.